SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 84 filers reported holding SYNTA PHARMACEUTICALS CORP in Q3 2015. The put-call ratio across all filers is 1.53 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $221,000 | -32.8% | 934,220 | -0.8% | 0.00% | – |
| Q4 2015 | $329,000 | -79.9% | 941,667 | +0.0% | 0.00% | – |
| Q3 2015 | $1,634,000 | -23.1% | 941,271 | -1.0% | 0.00% | – |
| Q2 2015 | $2,124,000 | +38.2% | 950,644 | +20.2% | 0.00% | – |
| Q1 2015 | $1,537,000 | -26.6% | 790,866 | -0.1% | 0.00% | – |
| Q4 2014 | $2,095,000 | -10.1% | 791,411 | +2.2% | 0.00% | – |
| Q3 2014 | $2,330,000 | -25.1% | 774,506 | +1.9% | 0.00% | – |
| Q2 2014 | $3,110,000 | -7.2% | 759,989 | -2.3% | 0.00% | – |
| Q1 2014 | $3,352,000 | -60.5% | 778,198 | -35.0% | 0.00% | -100.0% |
| Q4 2013 | $8,486,000 | +121.4% | 1,197,560 | +97.2% | 0.00% | – |
| Q3 2013 | $3,833,000 | +26.3% | 607,275 | -0.2% | 0.00% | – |
| Q2 2013 | $3,034,000 | – | 608,371 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 28,639,349 | $123,436,000 | 94.21% |
| Verity Asset Management, Inc. | 103,021 | $456,000 | 0.47% |
| NBW CAPITAL LLC | 242,153 | $1,044,000 | 0.27% |
| Old West Investment Management, LLC | 69,997 | $301,000 | 0.19% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 196,639 | $848,000 | 0.12% |
| SOPHROSYNE CAPITAL LLC | 25,700 | $111,000 | 0.10% |
| Cutler Capital Management, LLC | 45,000 | $194,000 | 0.08% |
| Rotella Capital Management, Inc. | 11,700 | $50,000 | 0.06% |
| STONERIDGE INVESTMENT PARTNERS LLC | 66,397 | $286,000 | 0.06% |
| Roundview Capital LLC | 21,100 | $91,000 | 0.04% |